Skip to main content
MyCapitol LogoMyCapitol

S 4302 · 117th Congress

Biologics Market Transparency Act of 2022

This bill requires drug manufacturers to be more open about the prices they charge for biologic medications—drugs made from living cells that treat serious conditions like cancer, rheumatoid arthritis, and certain infections. Right now, these companies can keep their pricing strategies largely secret, which makes it…

Sponsor
Kaine, Tim (D-VA)
Introduced
2022-05-25
Policy area
Health
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)

Digging through Congress... 🔍